Statistics for Cogent Biosciences, (id:7873 COGT)
Valuation metrics
Market cap
1.07B
Enterprise value
941.71M
Trailing P/E (ttm)
-3.77
Forward P/E
-4.20
PEG ratio
-4.20
Price/Sales (ttm)
Price/Book (mrq)
5.22
Enterprise Value/Revenue
Enterprise Value/EBITDA
-3.65
Overview
Shares outstanding
109.45M
Float
70.88M
Shares short
8.43M
% Held by insiders
0.00%
% Held by institutions
1.12%
Average volume (10 days)
1.72M
Average volume (90 days)
Price summary
52-Week low
3.67
52-Week high
12.61
52-Week change
26.29%
Beta
0.02
50-Day moving average
11.06
200-Day moving average
8.69
Dividends and splits
Forward annual dividend rate
Forward annual dividend yield
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
November 09th, 2020
Ex-dividend date
Last split factor
2:1
Last split date
November 09th, 2020
Financials
Fiscal yearFiscal year ends
December 31th, 2023
Most recent quarter (mrq)
June 30th, 2024
Profitability
Profit margin
0.00%
Operating margin
0.00%
Operational effectiveness
Return on assets
-44.02%
Return on equity
-78.47%
Income statement
Revenue (ttm)
0.00
Revenue per share (ttm)
0.00
Quarterly revenue growth (yoy)
Gross profit (ttm)
0.00
EBITDA
-258,010,000.00
Net income to common (ttm)
-242,296,992.00
Diluted EPS (ttm)
-2.49
Quarterly earnings growth (yoy)
Balance sheet
Total cash (mrq)
335.52M
Total cash per share (mrq)
3.04
Total debt (mrq)
17.83M
Total Debt/Equity (mrq)
5.67
Current ratio (mrq)
643.80%
Book value per share (mrq)
1.85
Cash flow
Cash flow statement
-191,284,000.00
Levered free cash flow (LFCF)
-101,876,624.00